Enliven Therapeutics, Inc. (ELVN)
41.65
+0.42
(+1.02%)
USD |
NASDAQ |
May 01, 16:00
41.65
0.00 (0.00%)
After-Hours: 20:00
Enliven Therapeutics EPS Diluted (Quarterly) : -0.4769 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | -1.715 |
| Terns Pharmaceuticals, Inc. | -0.2395 |
| Madrigal Pharmaceuticals, Inc. | -2.566 |
| Sarepta Therapeutics, Inc. | -3.934 |
| Kodiak Sciences, Inc. | -1.042 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -29.67M |
| Total Expenses (Quarterly) | 29.67M |
| Enterprise Value | 2.003B |
| Earnings Yield | -4.46% |
| Normalized Earnings Yield | -4.461 |